You are correct in saying that it "Wasn't A Whim Purchase" More accurately though, it wasn't a "purchase" at all, and it sure as heck wasn't a purchase by any one party!
Hmm...let's not forget that Deep Track Capital invested $50 Million with Anavex at a price of $21/share last year...so they obviously liked the data from the PDD P2 trial.
And our science has only progressed further since they invested last year...so don't be surprised if we get another large investment if the TLD for the Rett P3 trial is good.
News 
Market Data 
Discover 
